Li Chen,Xiangxian Zhang,Yu Liu,Li Liu,Xiao Liang,Shengqun Yang,Qing Xia,Tao Jin,Yun Ma,Yonghua Chen,Xia Yuan,Yan Tie,Yangzhuo Gu,Chunju Fang,Siyuan Chen,Fei Mo,Ting Yu,Yuzhu Hu,Zhiyong Qian,Yong Peng,Jia Geng,Zongguang Zhou,Min Wu,Jiansheng Ding,Daoke Yang,Xiawei Wei

Abstract:Acute pancreatitis (AP) can be complicated by inflammatory disorders of remote organs, such as lung injury, in which Jumonji domain-containing protein 3 (JMJD3) plays a vital role in proinflammatory responses. Currently, we found that JMJD3 expression was upregulated in the pancreas and lung in an AP male mouse model, which was also confirmed in AP patients. Further experiments revealed that the upregulation of JMJD3 and proinflammatory effects were possibly exerted by mitochondrial DNA (mtDNA) or oxidized-mtDNA from tissue injury caused by AP. The release of mtDNA and oxidized-mtDNA contributed to the infiltration of inflammatory monocytes in lung injury through the stimulator of IFN genes (STING)/TLR9-NF-κB-JMJD3-TNF-α pathway. The inhibition of JMJD3 or utilization of Jmjd3-cKO mice significantly alleviated pulmonary inflammation induced by AP. Blocking mtDNA oxidation or knocking down the TLR9/STING pathway effectively alleviated inflammation. Therefore, inhibition of JMJD3 or STING/TLR9 pathway blockage might be a potential therapeutic strategy to treat AP and the associated lung injury.

JMJD3 is Required for Acute Pancreatitis and Pancreatitis-Associated Lung Injury.